NEW YORK (GenomeWeb News) – America's Choice Provider Network will now cover CombiMatrix's diagnostic laboratory services, CombiMatrix said today.

ACPN is a San Diego-based company that facilitates out-of-network services for more than 540 payers in the US, reaching about 14 million people. Under the new agreement, individuals whose healthcare providers liaise with ACPN will now have access to CombiMatrix's menu of chromosomal microarray-based prenatal, pediatric, and cancer cytogenetic testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.